Early desensitization of somato-dendritic 5-HT1A autoreceptors in rats treated with fluoxetine or paroxetine (original) (raw)
References
Artigas F, Perez V, Alvarez E (1994) Pindolol induces a rapid improvement of patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 51:248–251 Google Scholar
Blier P, de Montigny C (1987) Modification of 5-HT neuron properties by sustained administration of the 5-HT1A agonist gepirone: electrophysiological studies in the rat brain. Synapse 1:470–480 Google Scholar
Briley M, Moret C (1993) Neurobiological mechanisms involved in antidepressant therapies. Clin Neuropharmacol 16:387–400 Google Scholar
Caldecott-Hazard S, Morgan DG, De Leon-Jones F, Overstreet DH, Janowsky D (1991) Clinical and biochemical aspects of depressive disorders: II. Transmitter/receptor theories. Synapse 9:251–301 Google Scholar
Chang AS, Chang SM, Starnes DM (1993) Structure-activity relationships of serotonin transport: relevance to nontricyclic antidepressant interactions. Fur J Pharmacol 247:239–248 Google Scholar
Chaput Y, Blier P, De Montigny C (1988) Acute and long-term effects of antidepressant serotonin (5-HT) reuptake blockers on the efficacy of 5-HT neurotransmission: electrophysiological studies in the rat central nervous system. Adv Biol Psychiatry 17:1–17 Google Scholar
De Montigny C, Blier P, Chaput Y (1990) Electrophysiological investigation of the effects of antidepressant treatments on serotonin receptors. In: Vanhoutte PM, Paoletti R, Brunello N, Maggi FM (eds) Serotonin: from cell biology to pharmacology and therapeutics. Kluwer Acad Publ, Dordrecht, pp 499–504 Google Scholar
Delgado PL, Charney DS, Price LH, Aghajanian GK, Landis H, Heninger GR (1990) Serotonin function and the mechanism of antidepressant action: reversal of antidepressant induced remission by rapid depletion of plasma tryptophan. Arch Gen Psychiatry 47:411–418 Google Scholar
Emerit MB, El Mestikawy S, Gozlan H, Rouot B, Hamon M (1990) Physical evidence of the coupling of solubilized 5-HT1A binding sites with G regulatory proteins. Biochem Pharmacol 39:7–18 Google Scholar
Fletcher A, Bill DJ, Cliffe IA, Forster EA, Jones D, Reilly Y (1994) A pharmacological profile of WAY-100635, a potent and selective 5-HT1A receptor antagonist. Br J Pharmacol 112:91P
Fuller RW (1994) Minireview: Uptake inhibitors increase extracellular serotonin concentration measured by brain microdialysis. Life Sci 55:163–167 Google Scholar
Fuller RW, Wong DT, Robertson DW (1991) Fluoxetine, a selective inhibitor of Serotonin uptake. Med Res Rev 11:17–34 Google Scholar
Gobbi M, Frittoli E, Mennini T, Garattini S (1992) Releasing activities of d-fenfluramine and fluoxetine on rat hippocampal synaptosomes preloaded with [3H]Serotonin. NaunynSchmiedeberg's Arch Pharmacol 345:1–6 Google Scholar
Gozlan H, Thibault S, Laporte A, Lima L, Hamon M (1995) The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes. Fur J Pharmacol-Mol Pharmacol 288:173–186 Google Scholar
Haj-Dahmane S, Hamon M, Lanfumey L (1991) K+ channel and 5-hydroxytryptamine1A autoreceptor interactions in the rat dorsal raphe nucleus: an in vitro electrophysiological study. Neuroscience 41:495–505 Google Scholar
Hall MD, El Mestikawy S, Emerit MB, Pichat L, Hamon M, Gozlan H (1985) [3H]8-hydroxy-2-(di-n-propylamino)tetralin binding to pre- and post- synaptic 5-hydroxytryptamine sites in various regions of the rat brain. J Neurochem 44:1685–1696 Google Scholar
Hensler JG, Kovachich GB, Frazer A (1991) A quantitative autoradiographic study of serotonin1A receptor regulation. Effect of 5,7-dihydroxytryptamine and antidepressant treatments. Neuropsychopharmacology 4:131–144 CASPubMed Google Scholar
Hoyer D, Clarke D, Fozard J, Hartig P, Martin G, Mylecharane E, Saxena P, Humphrey P (1994) VII. International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol Rev 46:157–203 Google Scholar
Hyttel J (1994) Pharmacological characterization of selective scrotonin reuptake inhibitors (SSRIs). Int Clin Psychopharmacol 9 [suppl 1]:19–26 Google Scholar
Jolas T, Haj-Dahmane S, Kidd EJ, Langlois X, Lanfumey L, Fattaccini CM, Vantalon V, Laporte AM, Adrien J, Gozlan H, Hamon M (1994) Central pre- and postsynaptic 5-HT1A receptors in rats treated chronically with a novel antidepressant, cericlamine. J Pharmacol Exp Ther 268:1432–1443 Google Scholar
Jolas T, Haj-Dahmane S, Lanfumey L, Fattaccini CM, Kidd EJ, Adrien J, Gozlan H, Guardiola-Lemaitre B, Hamon M (1993) (−)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain. Naunyn-Schmiedeberg's Arch Pharmacol 347:453–463 Google Scholar
Kidd EJ, Haj-Dahmane S, Jolas T, Lanfumey L, Fattaccini CM, Guardiola-Lemaitre B, Gozlan H, Hamon M (1993) New methoxy-chroman derivatives, 4[N-(5-methoxy-chroman-3-yl) N-propylamino]butyl-8-azaspiro-(4,5)-decane-7,9-dione [(±)-S 20244] and its enantiomers, (+)-S 20499 and (−)-S 20500, with potent agonist properties at central 5-hydroxytryptamine1A receptor. J Pharmacol Exp Ther 264:863–872 Google Scholar
Lesch K (1993) 5-HT1 receptors in depression and related disorders. Eur Neuropsychopharmacol 3:302–303 Google Scholar
Lesch KP, Hough CJ, Aulakh CS, Wolozin BL, Tolliver TJ, Hill JL, Akiyoshi J, Chuang DM, Murphy DL (1992) Fluoxetine modulates G protein αs, αq, and α12 subunit mRNA expression in rat brain. Fur J Pharmacol-Mol Pharmacol 227:233–237 Google Scholar
Li Q, Brownfield MS, Levy AD, Battaglia G, Cabrera TM, Van de Kar LD (1994) Attenuation of hormone responses to the 5-HT1A agonist ipsapirone by long-term treatment with fluoxetine, but not desipramine, in male rats. Biol Psychiatry 36:300–308 Google Scholar
Maj J, Meryl E (1993) Effects of fluoxetine given chronically on the responsiveness of 5-HT receptor subpopulations to their agonists. Fur Neuropsychopharmacol 3:85–94 Google Scholar
Nemeroff CB (1993) Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression. J Clin Psychopharmacol 13:10S-17S Google Scholar
Newman ME, Lerer B, Shapira B (1993) 5-HTIA receptor-mediated effects of antidepressants. Prog Neuro-Psychopharmacol Biol Psychiatry 17:1–19 Google Scholar
Newman ME, Shapira B, Lerer B (1992) Regulation of 5-hydroxytryptamine1A receptor function in rat hippocampus by shortand long- term administration of 5-hydroxytryptamine1A agonists and antidepressants. J Pharmacol Exp Ther 260:16–20 Google Scholar
Rigdon GC, Wang CM (1991) Serotonin uptake blockers inhibit the firing of presumed serotonergic dorsal raphe neurons in vitro. Drug Dev Res 22:135–140 Google Scholar
Schechter LE, Bolafios FJ, Gozlan H, Lanfumey L, Haj-Dahmane S, Laporte AM, Fattaccini C, Hamon M (1990) Alterations of central serotoninergic and dopaminergic neurotransmission in rats chronically treated with ipsapirone: biochemical and electrophysiological studies. J Pharmacol Exp Ther 255:1335–1347 Google Scholar
Scheffel U, Kim S, Cline EJ, Kuhar MJ (1994) Occupancy of the serotonin transporter by fluoxetine, paroxetine, and sertraline: in vivo studies with [125I]RTI-55. Synapse 16:263–268 Google Scholar
Snedecor GW, Cochran WG (1967) Statistical methods. Iowa State College Press, Ames Google Scholar
Spurlock G, Buckland P, O'Donovan M, McGuffin P (1994) Lack of effect of antidepressant drugs on the levels of mRNAs encoding serotonergic receptors, synthetic enzymes and 5-HT transporter. Neuropharmacology 33:433–440 ArticleCASPubMed Google Scholar
Stahl SM, Gastpar M, Keppel Hesselink JM, Traber J (eds) (1992) Serotonin1A receptors in depression and anxiety. Raven Press, New York, 216 p Google Scholar
Thomas DR, Nelson DR, Johnson AM (1987) Biochemical effects of the antidepressent paroxetine, a specific 5-hydroxytryptamine uptake inhibitor. Psychopharmacology 93:193–200 Google Scholar
Tignol J (1993) A double-blind, randomized, fluoxetine-controlled, multicenter study of paroxetine in the treatment of depression. J Clin Psychopharmacol 13:18S-22S Google Scholar
Vandermaelen CP, Agbajanian GK (1983) Electrophysiological and pharmacological characterization of serotoninergic dorsal raphe neurons recorded extracellularly and intracellularly in rat brain slices. Brain Res 289:109–119 Google Scholar
Welner SA, De Montigny C, Desroches J, Desjardins P, Suranyi-Cadotte BE (1989) Autoradiographic quantification of serotonin1A receptors in rat brain following antidepressant drug treatment. Synapse 4:347–352 CASPubMed Google Scholar
Wieland S, Fischette CT, Lucki I (1993) Effect of chronic treatments with tandospirone and imipramine on Serotonin-mediated behavioral responses and monoamine receptors. Neuropbarmacology 32:561–573 Google Scholar
Wong DT, Threlkeld PG, Robertson DW (1991) Affinities of fluoxetine, its enantiomers, and other inhibitors of scrotonin uptake for subtypes of serotonin receptors. Neuropsychopharmacology 5:43–47 Google Scholar
Yates M, Ferrier IN (1990) 5-HTIA receptors in major depression. J Psychopharmacol 4:69–74 Google Scholar